Inventaa Industries is an API manufacturer based in India. It holds one active US drug master file. Its most recent recorded inspection, by US FDA, closed on 28 June 2018 as NAI. Customs aggregates show $1.6M of exports covering 20 molecules to 8 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| India, India | 3003903069 |
| Molecule | Regulators | Docs |
|---|---|---|
| Trimethoprim | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $612K | 3 |
| 2025 | Not reported | $1.6M | 8 |
| 2024 | Not reported | $1.5M | 9 |
| 2023 | Not reported | $2.7M | 8 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Inventaa Industries comes back tiered against every other supplier able to file there.
Start for free